Page last updated: 2024-10-21

ethylisopropylamiloride and Acute Myelogenous Leukemia

ethylisopropylamiloride has been researched along with Acute Myelogenous Leukemia in 1 studies

ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.

Research Excerpts

ExcerptRelevanceReference
" In contrast to the discrepancy in Tyrphostin dose-response curves, titration curves for 5-(N-ethyl-n-isopropyl)amiloride and 5-(N,N-hexamethylene)amiloride are comparable in SF- or GM-CSF-stimulated cells."1.29Product of the steel locus suppresses apoptosis in hemopoietic cells. Comparison with pathways activated by granulocyte macrophage colony-stimulating factor. ( Cáceres-Cortés, J; Dumouchel, J; Haddad, P; Hoang, T; Rajotte, D, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cáceres-Cortés, J1
Rajotte, D1
Dumouchel, J1
Haddad, P1
Hoang, T1

Other Studies

1 other study available for ethylisopropylamiloride and Acute Myelogenous Leukemia

ArticleYear
Product of the steel locus suppresses apoptosis in hemopoietic cells. Comparison with pathways activated by granulocyte macrophage colony-stimulating factor.
    The Journal of biological chemistry, 1994, Apr-22, Volume: 269, Issue:16

    Topics: Alkaloids; Amiloride; Animals; Apoptosis; Bone Marrow; Bone Marrow Cells; Catechols; Cell Division;

1994